Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agentix
AddedFeb 20, 2024
UpdatedJun 18, 2026
Agentix

Agentix

Public

Agentix, a biopharmaceutical firm, develops health solutions and modulates the ECS for therapeutic targets, based in California.

HQ
Dana Point, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Agentix, founded in California, is a clinical-stage biopharmaceutical company dedicated to developing innovative health solutions targeting the endocannabinoid system (ECS). Their mission is to address metabolic diseases such as Type 2 Diabetes Mellitus, Chronic Obesity, and Non-alcoholic Fatty Liver Disease through a suite of novel, science-driven biopharmaceuticals. By focusing on synthetic agonists, inverse agonists, and antagonists that modulate ECS, Agentix aims to offer therapeutic solutions with greater market exclusivity.

Notable figures associated with Agentix include experienced scientists and industry veterans who drive its research and development efforts. The company has attracted significant investment from stakeholders interested in pioneering treatments for metabolic diseases. Key achievements include progressing to clinical-stage trials and developing a robust pipeline of ECS-targeting therapeutics. Agentix's impact lies in its potential to revolutionize the treatment of metabolic disorders, offering new hope to patients worldwide.

Agentix - Similar Companies

AgeX Therapeutics logo

AgeX Therapeutics

Spinogenix logo

Spinogenix

spinogenix.com

Adrx logo

Adrx

adrxpharma.com

Equator Therapeutics logo

Equator Therapeutics

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Endpoint Health logo

Endpoint Health

Aptinyx logo

Aptinyx

aptinyx.com

Demetrix logo

Demetrix

demetrix.com

Revagenix logo

Revagenix

revagenix.com

Endogenx logo

Endogenx

Sojournix logo

Sojournix

Artiam Bio logo

Artiam Bio

artiambio.net

Agile Sciences logo

Agile Sciences

agilesci.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Axial logo

Axial

axialvc.com

Agentix - Quick Facts

Who are Agentix's competitors?

Companies similar to Agentix include AgeX Therapeutics, Spinogenix, Adrx and Equator Therapeutics.

When was Agentix founded?

Agentix was founded in 2013.

Where is Agentix's headquarters located?

Agentix's headquarters is located in Dana Point, CA, US.

When was Agentix's last funding round?

Agentix's most recent funding round was for $688.3k (USD) in February 2021.

How much has Agentix raised to-date?

As of Feb 10, 2021, Agentix has raised a total of $808.3k (USD).

How many employees does Agentix have?

Agentix has 7 employees as of Feb 5, 2024.

Agentix - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Healthtech
Unique IDs
  • ein: 462876282
  • secCik: 0001603345
  • ticker: AGTX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325200Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing
  • 325210Resin and Synthetic Rubber Manufacturing
  • 325211Plastics Material and Resin Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2820Plastics Materials And Synthetic Resins, Synthetic Rubber, Cellulosic Manmade Fibers
  • 2821Plastics Materials, Synthetic Resins, And Nonvulcanizable Elastomers
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2013Manufacture of plastics and synthetic rubber in primary forms